NCT06636123 2026-01-27
GZ17-6.02 in Advanced CRPC After Progression on Anti-Androgen Therapy
Virginia Commonwealth University
Phase 1 Recruiting
Clinical Trials
5 trialsNCT06343038 2024-08-14
PROGNOSTICS
University Hospital, Basel, Switzerland
Phase 1 Recruiting
NCT02207504 2022-01-06
Crizotinib in Combination With Enzalutamide in Metastatic Castration-resistant Prostate Cancer
Dana-Farber Cancer Institute
Phase 1 Completed
NCT03136640 2021-10-19
ModraDoc006/r in Metastatic Castration-resistant Prostate Cancer
Modra Pharmaceuticals
Phase 1 Completed
NCT01634061 2020-12-09
Phase Ib of Abiraterone Acetate Plus BEZ235 or BKM120 in Castration-resistant Prostate Cancer (CRPC) Patients
Novartis
Phase 1 Completed